Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Contributing writer

Rebecca Nguyen, MB, BS, FACD
Skin and Cancer Foundation, Monash Health and Eastern Health
Melbourne, Australia

Rebecca Nguyen is a consultant dermatologist at the Skin and Cancer Foundation, Monash Health and Eastern Health, Melbourne, Australia. She completed her dermatology training in 2016 and has published as lead author on 8 peer-reviewed manuscripts. Dr. Nguyen is a 2019 IPC International Fellow and as part of her yearlong fellowship will work with IPC Professor Carle Paul in the dermatology department of Paul Sabatier University in Toulouse, France.

Last Updated: Aug 13, 2019

  

Latest news

March 30, 2021
Learn how psoriasis severity is currently measured and why a change is necessary, how IPC organized the Delphi process that was used to redefine severity classification, implications and effects the output has on psoriasis treatment providers and psoriasis patients, and ultimately how patients will benefit from this endeavor.
March 29, 2021
Janssen Pharmaceutical Companies of Johnson & Johnson published the long-term data of the third phase of the DISCOVER-2a study.
March 28, 2021
Sun Pharmaceutical Industries Inc. announces results from their five-year Phase-3 efficacy and safety clinical trial for ILUMYA®(tildrakizumab-asmn) based on a pooled analysis of the ReSURFACE 1 and ReSURFACE 2 extension.
March 17, 2021
Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1002 cases.
  More News

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK